Gallbladder cancer (GBC) is an extremely aggressive biliary tract malignancy characterized by silent early progression, late-stage diagnosis and poor prognosis. It is one of the most lethal gastrointestinal cancers, with a five-year survival rate often below 10%, partly because only about 10-20% of patients are eligible for curative surgical resection at diagnosis. 

A key focus of molecular research is whether Actionable Genomic Alterations (AGAs) – specific DNA changes in cancer cells – independently impact survival beyond established factors like stage and treatment.

A new study by researchers at Boston University Chobanian & Avedisian School of Medicine has found that patients with gallbladder cancer who had certain documented gene changes in their tumor had a higher risk of death, even when we compared them with similar patients based on age, sex, race/ethnicity, cancer stage, surgery and chemotherapy.

Neurological diseases are an increasing public health challenge in China. A recent meta-analysis of 12 disorders shows a rising overall burden, with intracerebral hemorrhage as the leading cause and dementia as the fastest-growing condition. Several disorders rose sharply between 2019 and 2021, coinciding with the onset of the COVID-19 pandemic. These findings indicate shifting disease patterns and highlight the need for improved prevention, early detection, and long-term care strategies nationwide.